DOI QR코드

DOI QR Code

Sulforaphane Inhibits Growth of Human Breast Cancer Cells and Augments the Therapeutic Index of the Chemotherapeutic Drug, Gemcitabine

  • Hussain, Arif ;
  • Mohsin, Javeria ;
  • Prabhu, Sathyen Alwin ;
  • Begum, Salema ;
  • Nusri, Qurrat El-Ain ;
  • Harish, Geetganga ;
  • Javed, Elham ;
  • Khan, Munawwar Ali ;
  • Sharma, Chhavi
  • 발행 : 2013.10.30

초록

Phytochemicals are among the natural chemopreventive agents with most potential for delaying, blocking or reversing the initiation and promotional events of carcinogenesis. They therefore offer cancer treatment strategies to reduce cancer related death. One such promising chemopreventive agent which has attracted considerable attention is sulforaphane (SFN), which exhibits anti-cancer, anti-diabetic, and anti-microbial properties. The present study was undertaken to assess effect of SFN alone and in combination with a chemotherapeutic agent, gemcitabine, on the proliferative potential of MCF-7 cells by cell viability assay and authenticated the results by nuclear morphological examination. Further we analyzed the modulation of expression of Bcl-2 and COX-2 on treatment of these cells with SFN by RT-PCR. SFN showed cytotoxic effects on MCF-7 cells in a dose- and time-dependent manner via an apoptotic mode of cell death. In addition, a combinational treatment of SFN and gemcitabine on MCF-7 cells resulted in growth inhibition in a synergistic manner with a combination index (CI)<1. Notably, SFN was found to significantly downregulate the expression of Bcl-2, an anti-apoptotic gene, and COX-2, a gene involved in inflammation, in a time-dependent manner. These results indicate that SFN induces apoptosis and anti-inflammatory effects on MCF-7 cells via downregulation of Bcl-2 and COX-2 respectively. The combination of SFN and gemcitabine may potentiate the efficacy of gemcitabine and minimize the toxicity to normal cells. Taken together, SFN may be a potent anti-cancer agent for breast cancer treatment.

키워드

Sulforaphane;gemcitabine;chemoprevention;apoptosis;breast cancer

참고문헌

  1. Pacini S, Milano F, Pinzani P, et al (1999). Effects of gemcitabine in normal and transformed human lung cell cultures: cytotoxicity and increase in radiation sensitivity. Tumori, 85, 503-7.
  2. Meeran SM, Patel SN, Tollefsbol TO (2010). Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One, 5, 11457. https://doi.org/10.1371/journal.pone.0011457
  3. Misiewicz I, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T (2004). Sulforaphane mediated induction of a phase 2 detoxyfying enzyme NAD(P)H: quinine reductase and apoptosis in human lymphoblastoid cells. Acta Biochim Pol, 51, 711-21.
  4. Myzak MC, Dashwood RH (2006). Chemoprotection by sulforaphane: Keep one eye beyond keap1. Cancer Lett, 233, 208-18. https://doi.org/10.1016/j.canlet.2005.02.033
  5. Nadda N, Setia S, Vaish V, Sanyal SN (2012). Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib. Mol Cell Biochem (Epub ahead of print).
  6. Notarbartolo M, Poma P, Perri D, et al (2005). Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells.Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett, 224, 53-65. https://doi.org/10.1016/j.canlet.2004.10.051
  7. Pledgie-Tracy A, Sobolewski MD, Davidson NE (2007). Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther, 6, 1013-21.
  8. Plummer SM, Holloway KA, Manson MM, et al (1999). Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene, 18, 6013-20. https://doi.org/10.1038/sj.onc.1202980
  9. Rajendran P, Delage B, Dashwood WM, et al (2011). Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer, 10, 68. https://doi.org/10.1186/1476-4598-10-68
  10. Sharma C, Sadrieh L, Priyani A, et al (2011). Anti-carcinogenic effects of sulforaphane in association with its apoptosisinducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol, 35, 272-8. https://doi.org/10.1016/j.canep.2010.09.008
  11. Sharma R, Sharma A, Chaudhary P, et al (2012). Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane. Free Radic Biol Med, 52, 2177-85. https://doi.org/10.1016/j.freeradbiomed.2012.04.012
  12. Barcelo S, Gardiner JM, Gescher A, Chipman JK (1996). CYP2E1-mediated mechanism of antigenotoxicity of the broccoli constituent sulforaphane. Carcinogenesis, 17, 277-82. https://doi.org/10.1093/carcin/17.2.277
  13. Strouch MJ, Milam BM, Melstrom LG, et al (2009). The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas, 38, 409-15. https://doi.org/10.1097/MPA.0b013e318193a074
  14. Wang AG, Kim SU, Lee SH, et al (2005). Histone deacetylase1 contributes to cell cycle and apoptosis. Biol Pharm Bull, 28, 1966-70. https://doi.org/10.1248/bpb.28.1966
  15. Wang X, Govind S, Sajankila SP, et al (2011) Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res, 55, 1572-81. https://doi.org/10.1002/mnfr.201000560
  16. Basten GP, Bao Y, Williamson G (2002). Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) incultured cells. Carcinogenesis, 23, 1399-404. https://doi.org/10.1093/carcin/23.8.1399
  17. Bondesen BA, Mills ST, Kegley KM, Pavlath GK (2004). The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol, 287, 475-83. https://doi.org/10.1152/ajpcell.00088.2004
  18. Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H (2003). Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol, 194, 63-70. https://doi.org/10.1002/jcp.10186
  19. Chou TC, Talalay P (1984). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul, 22, 27-55. https://doi.org/10.1016/0065-2571(84)90007-4
  20. Fimognari C, Nusse M, Cesari R, et al (2002). Growth inhibition, cell cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 23, 581-6. https://doi.org/10.1093/carcin/23.4.581
  21. Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E (2011). Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res, 55, 999-1009. https://doi.org/10.1002/mnfr.201000547
  22. Doudican NA, Wen SY, Mazumder A, Orlow SJ (2012). Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stressmediated pathways. Oncol Rep, 28, 1851-8.
  23. Fimognari C, Lenzi M, Sciuscio D, Cantelli-Forti G, Hrelia P (2007). Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation. Ann N Y Acad Sci, 1095, 62-9. https://doi.org/10.1196/annals.1397.008
  24. Gabriel EM, Jatoi I (2012). Breast cancer chemoprevention. Expert Rev Anticancer Ther, 12, 223-8. https://doi.org/10.1586/era.11.206
  25. Gerhauser C, Klimo K, Heiss E, et al (2003). Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res, 523-4, 163-72. https://doi.org/10.1016/S0027-5107(02)00332-9
  26. Gibbs A, Schwartzman, J, Deng V, Alumkal J (2009). Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc Natl Acad Sci USA, 106, 16663-8. https://doi.org/10.1073/pnas.0908908106
  27. Hastak K, Alli E, Ford JM (2010). Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine and cisplatin. Cancer Res, 70, 7970-80. https://doi.org/10.1158/0008-5472.CAN-09-4521
  28. Kalra N, Roy P, Prasad S, Shukla Y (2008). Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sci, 82, 348-58. https://doi.org/10.1016/j.lfs.2007.11.006
  29. Huang TY, Chang WC, Wang MY, Yang YR, Hsu YC (2012). Effect of sulforaphane on growth inhibition in human brain malignant glioma GBM 8401 cells by means of mitochondrial- and MEK/ERK-mediated apoptosis pathway. Cell Biochem Biophys, 63, 247-59. https://doi.org/10.1007/s12013-012-9360-3
  30. Hussain A, Harish G, Prabhu SA, et al (2012). Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression. Cancer Epidemiol, 36, 387-93. https://doi.org/10.1016/j.canep.2012.07.005
  31. Hwang JT, Lee YK, Shin JI, Park OJ (2009). Anti-inflammatory and anticarcinogenic effect of genistein alone or in combination with capsaicin in TPA-treated rat mammary glands or mammary cancer cell line. Ann N Y Acad Sci, 1171, 415-20. https://doi.org/10.1111/j.1749-6632.2009.04696.x
  32. Kanematsu S, Yoshizawa K, Uehara N, et al (2011). Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep, 26, 603-8.
  33. Karikas GA (2010). Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. J BUON, 15, 627-38.
  34. Khan AQ, Khan R, Rehman MU, et al (2012). Soy isoflavones (daidzein and genistein) inhibit 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cutaneous inflammation via modulation of COX-2 and NF-${\kappa}B$ in Swiss albino mice. Toxicol, (Epub ahead of print).
  35. Kim HJ, Park HJ, Park HK, Chung JH (2009). Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol, 262, 171-4. https://doi.org/10.1016/j.tox.2009.06.004
  36. Kumi-Diaka J, Merchant K, Haces A, Hormann V, Johnson M (2012). Genistein-selenium combination induces growth arrest in prostate cancer cells. J Med Food, 13, 842-50.
  37. Kotowski U, Heiduschka G, Brunner M, et al (2011). Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane. Strahlenther Onkol, 187, 575-80. https://doi.org/10.1007/s00066-011-2218-6
  38. Kuhar M, Imran S, Singh N (2007). Curcumin and Quercetin Combined with Cisplatin to Induce Apoptosis in Human Laryngeal Carcinoma Hep-2 Cells through the Mitochondrial Pathway. J Cancer Molecules, 3, 121-8.
  39. Kumar R, Das M, Ansari KM (2012). Nexrutine(R) inhibits tumorigenesis in mouse skin and induces apoptotic cell death in human squamous carcinoma A431 and human melanoma A375 cells. Carcinogenesis, (Epub ahead of print).
  40. Lev-Ari S, Zinger H, Kazanov D, et al (2005). Curcumin synergistically potentiates the growth inhibitory and proapoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomed Pharmacother, 59, 276-80. https://doi.org/10.1016/S0753-3322(05)80045-9
  41. Li Y, Karagoz GE, Seo YH, et al (2012). Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50(Cdc37) complex and direct interactions with amino acids residues of Hsp90. J Nutr Biochem (Epub ahead of print).
  42. Liu JD, Chen SH, Lin CL, Tsai SH, Liang YC (2001). Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. J Cell Biochem, 83, 631-42. https://doi.org/10.1002/jcb.1261
  43. Youlden DR, Cramb SM, Dunn NA, et al (2012).The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol, 36, 237-48. https://doi.org/10.1016/j.canep.2012.02.007

피인용 문헌

  1. Diet components can suppress inflammation and reduce cancer risk vol.8, pp.3, 2014, https://doi.org/10.4162/nrp.2014.8.3.233
  2. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition vol.22, pp.16, 2015, https://doi.org/10.1089/ars.2014.6097
  3. Protease activated receptor-2 (PAR2): possible target of phytochemicals vol.33, pp.9, 2015, https://doi.org/10.1080/07391102.2014.986197
  4. Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-016-1910-5
  5. The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation vol.16, pp.12, 2015, https://doi.org/10.3390/ijms161226195
  6. In Vitro Evaluation of Sulforaphane and a Natural Analog as Potent Inducers of 5-Fluorouracil Anticancer Activity vol.23, pp.11, 2018, https://doi.org/10.3390/molecules23113040
  7. Broccoli and human health: immunomodulatory effect of sulforaphane in a model of colon cancer vol.69, pp.8, 2018, https://doi.org/10.1080/09637486.2018.1439901
  8. Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives vol.25, pp.5, 2018, https://doi.org/10.1007/s12282-018-0866-4
  9. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives vol.8, pp.52, 2018, https://doi.org/10.1039/C8RA04879G